Recommended

New webinar: Overcoming critical challenges in AI-driven drug discovery
Watch on demand: Rapid cell-based profiling of multi-target anti-obesity drugs Watch here!
Download now: Unlock the power of stem cell therapy and discover the potential for new therapies for primary open-angle glaucoma
Brand new Beyond the Lab report on antibodies… Download NOW!

List view / Grid view

Dr Amy Yeung

 

article

New drug targets identified to defend against chlamydia infections using CRISPR and stem cells

Human induced pluripotent stem cell derived macrophages (iPSDMs) provide a…

7 July 2017 | By

Human induced pluripotent stem cell derived macrophages (iPSDMs) provide a cell-based model system to study chlamydia infection in the laboratory. Amy Yeung from Wellcome Trust Sanger Institute explains how she used this model in combination with CRISPR-Cas 9 technology to explore the potential of the two genes, IRF5 and IL10RA,…

Targets in-depth focus digital issue #2 2017
Targets in-depth focus digital issue #2 2017
article

Targets In-Depth Focus 2017

Included in this Targets In-Depth Focus: Intracellular target validation in…

5 June 2017 | By

Included in this Targets In-Depth Focus: Intracellular target validation in cellular systems; New drug targets identified to defend against chlamydia infections using CRISPR and stem cells; Novel solutions for tough targets with real bite...